Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Tuesday, November 10, 2009, 9:16PM ET - U.S. Markets Closed. Dow Up 0.20% Nasdaq Down 0.14%
Advanced Cell Technology Inc. (ACTC.OB)At 3:58PM ET: 0.098  Down 0.001 (0.91%)  
MORE ON ACTC.OB
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Advanced Cell Technology Inc.
381 Plantation Street
Biotech V
Worcester, MA 01605
United States - Map
Phone: 508-756-1212
Fax: 508-756-4468
Web Site: http://www.advancedcell.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:N/A

BUSINESS SUMMARY 
Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. It primarily focuses on cellular reprogramming, reduced complexity program, and stem cell differentiation research programs. The company develops adult stem cell-based products that are specifically targeted at therapies for heart and other cardiovascular diseases. Its stem cell-based therapy would provide treatment for an array of chronic degenerative diseases and in the regenerative repair of acute disease, such as trauma, infarction, and burns. It also has a joint venture agreement with CHA Biotech Co. Limited to develop human blood cells and other clinical therapies based on the company’s proprietary hemangioblast cell technology. The company is headquartered in Worcester, Massachusetts.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Advanced Cell Technology Inc.


    KEY EXECUTIVES 
     PayExercised
    Mr. William M. Caldwell IV, 61
    Chairman, Chief Exec. Officer, Principal Financial Officer, Principal Accounting Officer and Member of Compensation Committee
    N/A N/A
    Dr. Robert P. Lanza M.D., 52
    Chief Scientific Officer
    N/A N/A
    Dr. Michael D. West Ph.D., 55
    Consultant
    N/A N/A
    Ms. Rita Parker ,
    Director of Operations
    N/A N/A
    Dr. R. Geoffrey Sargent Ph.D.,
    Member of Sr. Scientific Team and Consultant
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis